Yuki Mizuta

Associate Director
Takeda Pharmaceutical Company Ltd., Osaka, Japan
Chuo-ku, Osaka, Japan

Presentation(s):

• PB1182 - Evaluation of Factor VIII Population Pharmacokinetics and Exposure-Response to Support Dosing of Recombinant Porcine Factor VIII in Patients with Acquired Hemophilia A

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT